| Companies sponsors |
GlaxoSmithKline (dostarlimab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Black Health Agency for Equality |
| |
Cancer Black Care |
| |
Cancer Equality |
| |
Cancer 52 |
| |
Endometriosis Foundation |
| |
Endometriosis UK |
| |
Eve Appeal |
| |
Helen Rollason Cancer Charity |
| |
Independent Cancer Patients Voice |
| |
Macmillan Cancer Support |
| |
Maggie’s Centres |
| |
Marie Curie |
| |
Peaches Womb Cancer Trust |
| |
South Asian Health Foundation |
| |
Specialised Healthcare Alliance |
| |
Tenovus Cancer Care |
| |
Wellbeing of Women |
| |
Womb Cancer Support UK |
| |
Women’s Health Concern |
| Professional groups |
Association of Anaesthetists |
| |
Association of Cancer Physicians |
| |
Association of Surgeons of Great Britain and Ireland |
| |
British Association of Surgical Oncology |
| |
British Geriatrics Society |
| |
British Gynaecological Cancer Society |
| |
British Institute of Radiology |
| |
British Oncology Pharmacy Association |
| |
British Psychosocial Oncology Society |
| |
British Society for Clinical Cytology |
| |
British Society for Colposcopy and Cervical Pathology |
| |
Cancer Research UK |
| |
National Forum of Gynaecological Oncology Nurses |
| |
Royal College of Anaesthetists |
| |
Royal College of General Practitioners |
| |
Royal College of Nursing |
| |
Royal College of Obstetricians and Gynaecologists |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
Royal College of Surgeons |
| |
Royal Pharmaceutical Society |
| |
Royal Society of Medicine |
| |
Society and College of Radiographers |
| |
UK Clinical Pharmacy Association |
| |
UK Oncology Nursing Society |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
Accord (carboplatin, paclitaxel, cisplatin, doxorubicin) |
| |
Alliance Healthcare (cyclophosphamide, paclitaxel) |
| |
AstraZeneca (durvalumab, olaparib) |
| |
Bausch & Lomb (megestrol acetate) |
| |
Baxter Healthcare (cyclophosphamide) |
| |
Bristol Myers Squibb Pharmaceuticals (paclitaxel) |
| |
Consilient Health (carboplatin) |
| |
Fresenius Kabi (carboplatin, paclitaxel) |
| |
Hospira UK (carboplatin, paclitaxel) |
| |
Johnson & Johnson Innovative Medicine (doxorubicin) |
| |
Medac GmbH (doxorubicin) |
| |
Merck Sharp & Dohme (pembrolizumab) |
| |
Novartis (cisplatin, cyclophosphamide) |
| |
Pfizer (carboplatin, paclitaxel, cisplatin, doxorubicin, medroxyprogesterone acetate) |
| |
Sandoz (cyclophosphamide) |
| |
Seacross Pharmaceuticals (paclitaxel, doxorubicin) |
| |
Teva UK (carboplatin, paclitaxel) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
Allied Health Professionals Federation |
| |
Board of Community Health Councils in Wales |
| |
British National Formulary |
| |
Care Quality Commission |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
National Association of Primary Care |
| |
National Pharmacy Association |
| |
NHS Confederation |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Genomics England |
| |
Institute of Cancer Research |
| |
MRC Clinical Trials Unit |
| |
National Institute for Health Research |